These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 35197311)

  • 1. Mathematical Models to Characterize the Absorption, Distribution, Metabolism, and Excretion of Protein Therapeutics.
    Liu S; Shah DK
    Drug Metab Dispos; 2022 Jun; 50(6):867-878. PubMed ID: 35197311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption, Distribution, Metabolism, and Excretion of Therapeutic Proteins: Current Industry Practices and Future Perspectives.
    Bolleddula J; Brady K; Bruin G; Lee A; Martin JA; Walles M; Xu K; Yang TY; Zhu X; Yu H
    Drug Metab Dispos; 2022 Jun; 50(6):837-845. PubMed ID: 35149541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
    Lüpfert C; Reichel A
    Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologically-based modeling of monoclonal antibody pharmacokinetics in drug discovery and development.
    Glassman PM; Balthasar JP
    Drug Metab Pharmacokinet; 2019 Feb; 34(1):3-13. PubMed ID: 30522890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and Pharmacodynamic Modeling of siRNA Therapeutics - a Minireview.
    Jeon JY; Ayyar VS; Mitra A
    Pharm Res; 2022 Aug; 39(8):1749-1759. PubMed ID: 35819583
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Amaeze O; Isoherranen N; Shum S
    Drug Metab Dispos; 2024 May; ():. PubMed ID: 38811157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Influencing ADME Properties of Therapeutic Antisense Oligonucleotides: Physicochemical Characteristics and Beyond.
    Jiang R; Hooshfar S; Rebecca Eno M; Yun C; Sonego Zimmermann E; Shinkyo R
    Curr Drug Metab; 2023; 24(7):536-552. PubMed ID: 37076460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of
    McDougall R; Ramsden D; Agarwal S; Agarwal S; Aluri K; Arciprete M; Brown C; Castellanos-Rizaldos E; Charisse K; Chong S; Cichocki J; Fitzgerald K; Goel V; Gu Y; Guenther D; Habtemariam B; Jadhav V; Janas M; Jayaraman M; Kurz J; Li J; Liu J; Liu X; Liou S; Maclauchlin C; Maier M; Manoharan M; Nair JK; Robbie G; Schmidt K; Smith P; Theile C; Vaishnaw A; Waldron S; Xu Y; Zhang X; Zlatev I; Wu JT
    Drug Metab Dispos; 2022 Jun; 50(6):781-797. PubMed ID: 34154993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs.
    Migliorati JM; Liu S; Liu A; Gogate A; Nair S; Bahal R; Rasmussen TP; Manautou JE; Zhong XB
    Drug Metab Dispos; 2022 Jun; 50(6):888-897. PubMed ID: 35221287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically based pharmacokinetic models of small molecules and therapeutic antibodies: a mini-review on fundamental concepts and applications.
    Ferl GZ; Theil FP; Wong H
    Biopharm Drug Dispos; 2016 Mar; 37(2):75-92. PubMed ID: 26461173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders.
    Volak LP; Duevel HM; Humphreys S; Nettleton D; Phipps C; Pike A; Rynn C; Scott-Stevens P; Zhang D; Zientek M
    Drug Metab Dispos; 2023 Jul; 51(7):792-803. PubMed ID: 37041086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key Physicochemical Characteristics Influencing ADME Properties of Therapeutic Proteins.
    Jing X; Hou Y; Hallett W; Sahajwalla CG; Ji P
    Adv Exp Med Biol; 2019; 1148():115-129. PubMed ID: 31482497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development.
    Tibbitts J; Canter D; Graff R; Smith A; Khawli LA
    MAbs; 2016; 8(2):229-45. PubMed ID: 26636901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of
    Ayyar VS; Song D; Zheng S; Carpenter T; Heald DL
    J Pharmacol Exp Ther; 2021 Nov; 379(2):134-146. PubMed ID: 34413198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Pediatric Modeling and Simulation Using Ontogeny Information.
    Ince I; Solodenko J; Frechen S; Dallmann A; Niederalt C; Schlender J; Burghaus R; Lippert J; Willmann S
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S95-S103. PubMed ID: 31502689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeutics.
    Shah DK
    J Pharmacokinet Pharmacodyn; 2015 Oct; 42(5):553-71. PubMed ID: 26373957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression databases for physiologically based pharmacokinetic modeling of humans and animal species.
    Cordes H; Rapp H
    CPT Pharmacometrics Syst Pharmacol; 2023 Mar; 12(3):311-319. PubMed ID: 36715173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tools for predicting the PK/PD of therapeutic proteins.
    Diao L; Meibohm B
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1115-25. PubMed ID: 25936400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.
    Ayyar VS; Jusko WJ
    Pharmacol Rev; 2020 Apr; 72(2):414-438. PubMed ID: 32123034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research.
    Cronin JM; Yu AM
    Drug Metab Dispos; 2023 Jun; 51(6):685-699. PubMed ID: 36948592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.